Astrana Health Q3 revenue $956M (+100% YoY); adjusted EBITDA $68.5M; closes Prospect Health

Astrana Health, Inc.

2025-Q3 EPS reported $0.33 vs consensus $0.45 ▼ miss (-26.7%)

Total revenue $956.0M, up 100% YoY; Care Partners revenue $897.7M, up 97%.
Adjusted EBITDA $68.5M, up 52% YoY; net income $0.4M, diluted EPS $0.01.
Closed Prospect Health acquisition; standalone Q3 performance exceeded expectations.
Full-year 2025 guidance updated for full-risk contract delays; expects completion in Q1 2026.
Reiterating full-year medical cost trend expectations; underlying performance strong.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.